Literature DB >> 15303969

Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity.

Yee-Ling Khu1, Yee-Joo Tan, Seng Gee Lim, Wanjin Hong, Phuay-Yee Goh.   

Abstract

NS3, a non-structural protein of the HCV (hepatitis C virus), contains a protease and a helicase domain and plays essential roles in the processing of the viral polyprotein, viral RNA replication and translation. LMP7 (low-molecular-mass protein 7), a component of the immunoproteasome, was identified as an NS3-binding protein from yeast two-hybrid screens, and this interaction was confirmed by in vitro binding and co-immunoprecipitation analysis. The minimal domain of interaction was defined to be between the pro-sequence region of LMP7 (amino acids 1-40) and the protease domain of NS3. To elucidate the biological importance of this interaction, we studied the effect of this interaction on NS3 protease activity and on LMP7 immunoproteasome activity. Recombinant LMP7 did not have any effect on NS3 protease activity in vitro. The peptidase activities of LMP7 immunoproteasomes, however, were markedly reduced when tested in a stable cell line containing a HCV subgenomic replicon. The down-regulation of proteasome peptidase activities could interfere with the processing of viral antigens for presentation by MHC class I molecules, and may thus protect HCV from host immune surveillance mechanisms to allow persistent infection by the virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303969      PMCID: PMC1134124          DOI: 10.1042/BJ20040858

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  Mutations that affect dimer formation and helicase activity of the hepatitis C virus helicase.

Authors:  Y L Khu; E Koh; S P Lim; Y H Tan; S Brenner; S G Lim; W J Hong; P Y Goh
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver.

Authors:  S Khan; M van den Broek; K Schwarz; R de Giuli; P A Diener; M Groettrup
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 3.  Optimal therapy of hepatitis C.

Authors:  Adrian M Di Bisceglie; Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor.

Authors:  W T Sing; C L Lee; S L Yeo; S P Lim; M M Sim
Journal:  Bioorg Med Chem Lett       Date:  2001-01-22       Impact factor: 2.823

Review 5.  The natural history of hepatitis C virus infection.

Authors:  E Kenny-Walsh
Journal:  Clin Liver Dis       Date:  2001-11       Impact factor: 6.126

6.  Identification and molecular characterisation of the complete genome of a Singapore isolate of hepatitis C virus: sequence comparison with other strains and phylogenetic analysis.

Authors:  S P Lim; Y L Khu; W J Hong; A Tay; A E Ting; S G Lim; Y H Tan
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

Review 7.  Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why?

Authors:  M Groettrup; S Khan; K Schwarz; G Schmidtke
Journal:  Biochimie       Date:  2001 Mar-Apr       Impact factor: 4.079

8.  Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex.

Authors:  Z Hu; Z Zhang; E Doo; O Coux; A L Goldberg; T J Liang
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

9.  Cell transformation induced by hepatitis C virus NS3 serine protease.

Authors:  R Zemel; S Gerechet; H Greif; L Bachmatove; Y Birk; A Golan-Goldhirsh; M Kunin; Y Berdichevsky; I Benhar; R Tur-Kaspa
Journal:  J Viral Hepat       Date:  2001-03       Impact factor: 3.728

10.  Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.

Authors:  A J Sijts; T Ruppert; B Rehermann; M Schmidt; U Koszinowski; P M Kloetzel
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  14 in total

1.  Characterization of the Interaction between the Matrix Protein of Vesicular Stomatitis Virus and the Immunoproteasome Subunit LMP2.

Authors:  Frauke Beilstein; Linda Obiang; Hélène Raux; Yves Gaudin
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Construction of eukaryotic expression plasmid containing HCV NS3 segment and protein expression in human HL-7702 hepatocytes.

Authors:  Jun-Wu Li; Ke Li; Jing Jiang; Xiao-Liang Xu; Ze-Qi Huang
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

3.  Roles of the two distinct proteasome pathways in hepatitis C virus infection.

Authors:  Ikuo Shoji
Journal:  World J Virol       Date:  2012-04-12

4.  The protease domain increases the translocation stepping efficiency of the hepatitis C virus NS3-4A helicase.

Authors:  Vaishnavi Rajagopal; Madhura Gurjar; Mikhail K Levin; Smita S Patel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

Review 5.  Hepatitis C virus and ethanol alter antigen presentation in liver cells.

Authors:  Natalia A Osna
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

6.  Herpes simplex virus type 2 UL56 interacts with the ubiquitin ligase Nedd4 and increases its ubiquitination.

Authors:  Yoko Ushijima; Tetsuo Koshizuka; Fumi Goshima; Hiroshi Kimura; Yukihiro Nishiyama
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

7.  Genetic polymorphisms of LMP/TAP gene and hepatitis B virus infection risk in the Chinese population.

Authors:  Changqing Xu; Suxia Qi; Lei Gao; Hong Cui; Meiqiang Liu; Hongli Yang; Kun Li; Bangwei Cao
Journal:  J Clin Immunol       Date:  2007-05-25       Impact factor: 8.317

Review 8.  Influence of host resistance on viral adaptation: hepatitis C virus as a case study.

Authors:  Anne Plauzolles; Michaela Lucas; Silvana Gaudieri
Journal:  Infect Drug Resist       Date:  2015-04-07       Impact factor: 4.003

9.  Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations.

Authors:  Ningjing Zou; Lan Yang; Ling Chen; Tingting Li; Tingting Jin; Hao Peng; Shumao Zhang; Dandan Wang; Ranran Li; Chunxia Liu; Jinfang Jiang; Lianghai Wang; Weihua Liang; Jianming Hu; Shugang Li; Chuanyue Wu; Xiaobin Cui; Yunzhao Chen; Feng Li
Journal:  J Exp Clin Cancer Res       Date:  2015-07-25

10.  Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals.

Authors:  Lisa Barrett; Maureen Gallant; Constance Howley; M Ian Bowmer; Geri Hirsch; Kevork Peltekian; Michael Grant
Journal:  BMC Immunol       Date:  2008-06-13       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.